Similar articles for PMID: 25399696

Year	Number of Results
1995	1
1999	1
2001	2
2003	1
2005	4
2006	3
2007	1
2008	2
2009	5
2010	3
2011	9
2012	8
2013	15
2014	14
2015	11
2016	12
2017	9
2018	8
2019	8
2020	10
2021	3
2022	4
2024	0

1

Regulation of cell cycle of hepatocellular carcinoma by NF90 through modulation of cyclin E1 mRNA stability.

Jiang W, Huang H, Ding L, Zhu P, Saiyin H, Ji G, Zuo J, Han D, Pan Y, Ding D, Ma X, Zhang Y, Wu J, Yi Q, Liu JO, Huang H, Dang Y, Yu L. Jiang W, et al. Oncogene. 2015 Aug 20;34(34):4460-70. doi: 10.1038/onc.2014.373. Epub 2014 Nov 17. Oncogene. 2015. PMID: 25399696 Free PMC article.

2

Expression of a cyclin E1 isoform in mice is correlated with the quiescent cell cycle status of hepatocytes in vivo.

Zschemisch NH, Liedtke C, Dierssen U, Nevzorova YA, Wüstefeld T, Borlak J, Manns MP, Trautwein C. Zschemisch NH, et al. Hepatology. 2006 Jul;44(1):164-73. doi: 10.1002/hep.21224. Hepatology. 2006. PMID: 16799991

3

HuR contributes to cyclin E1 deregulation in MCF-7 breast cancer cells.

Guo X, Hartley RS. Guo X, et al. Cancer Res. 2006 Aug 15;66(16):7948-56. doi: 10.1158/0008-5472.CAN-05-4362. Cancer Res. 2006. PMID: 16912169

4

Cyclin E1 and cyclin-dependent kinase 2 are critical for initiation, but not for progression of hepatocellular carcinoma.

Sonntag R, Giebeler N, Nevzorova YA, Bangen JM, Fahrenkamp D, Lambertz D, Haas U, Hu W, Gassler N, Cubero FJ, Müller-Newen G, Abdallah AT, Weiskirchen R, Ticconi F, Costa IG, Barbacid M, Trautwein C, Liedtke C. Sonntag R, et al. Proc Natl Acad Sci U S A. 2018 Sep 11;115(37):9282-9287. doi: 10.1073/pnas.1807155115. Epub 2018 Aug 27. Proc Natl Acad Sci U S A. 2018. PMID: 30150405 Free PMC article.

5

NF90 stabilizes cyclin E1 mRNA through phosphorylation of NF90-Ser382 by CDK2.

Ding D, Huang H, Li Q, Yu W, Wang C, Ma H, Wu J, Dang Y, Yu L, Jiang W. Ding D, et al. Cell Death Discov. 2020 Jan 22;6:3. doi: 10.1038/s41420-020-0236-9. eCollection 2020. Cell Death Discov. 2020. PMID: 32123579 Free PMC article.

6

Targeting ODC1 inhibits tumor growth through reduction of lipid metabolism in human hepatocellular carcinoma.

Choi Y, Oh ST, Won MA, Choi KM, Ko MJ, Seo D, Jeon TW, Baik IH, Ye SK, Park KU, Park IC, Jang BC, Seo JY, Lee YH. Choi Y, et al. Biochem Biophys Res Commun. 2016 Sep 30;478(4):1674-81. doi: 10.1016/j.bbrc.2016.09.002. Epub 2016 Sep 2. Biochem Biophys Res Commun. 2016. PMID: 27592554

7

NF90 regulates PARP1 mRNA stability in hepatocellular carcinoma.

Song D, Huang H, Wang J, Zhao Y, Hu X, He F, Yu L, Wu J. Song D, et al. Biochem Biophys Res Commun. 2017 Jun 17;488(1):211-217. doi: 10.1016/j.bbrc.2017.05.037. Epub 2017 May 6. Biochem Biophys Res Commun. 2017. PMID: 28487110

8

LncRNA LINC00470 promotes proliferation through association with NF45/NF90 complex in hepatocellular carcinoma.

Huang W, Liu J, Yan J, Huang Z, Zhang X, Mao Y, Huang X. Huang W, et al. Hum Cell. 2020 Jan;33(1):131-139. doi: 10.1007/s13577-019-00288-8. Epub 2019 Oct 14. Hum Cell. 2020. PMID: 31612313

9

Metformin suppresses hepatocellular carcinoma cell growth through induction of cell cycle G1/G0 phase arrest and p21CIP and p27KIP expression and downregulation of cyclin D1 in vitro and in vivo.

Cai X, Hu X, Cai B, Wang Q, Li Y, Tan X, Hu H, Chen X, Huang J, Cheng J, Jing X. Cai X, et al. Oncol Rep. 2013 Nov;30(5):2449-57. doi: 10.3892/or.2013.2718. Epub 2013 Sep 4. Oncol Rep. 2013. PMID: 24008375

10

Chromatin remodeling gene ARID2 targets cyclin D1 and cyclin E1 to suppress hepatoma cell progression.

Duan Y, Tian L, Gao Q, Liang L, Zhang W, Yang Y, Zheng Y, Pan E, Li S, Tang N. Duan Y, et al. Oncotarget. 2016 Jul 19;7(29):45863-45875. doi: 10.18632/oncotarget.10244. Oncotarget. 2016. PMID: 27351279 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

115 results

Results by year